Programme

Overview: Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will not be recorded.

Overview: Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.

Overview: Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.

Overview: This session will celebrate the best abstract submitted to each track. Join us in congratulating the winners during this plenary session and listen to the top-level presentations.

Overview: The Regaud Award is given in honour of Claudius Regaud. In 1911, Regaud described the principles of fractionation from his work on the testis and, in 1927, the need for quality and a multidisciplinary approach in cancer care. With Coutard, he introduced the principles of fractionation in clinical practice, a good example of translational research. "Observe and translate" was his message.

Overview: The "GEC-ESTRO Iridium Award" is presented to the brachytherapist or physicist who, in the opinion of the GEC-ESTRO Committee members, has made a major contribution to the development of the Brachytherapy speciality.

Overview: During this first ever joint symposium on cardio-oncology, the presenters will present the 2022 ESC guidelines on cardio-oncology, which were established multidisciplinary among big societies (ESTRO, ESC, EHA, ICOS). The current evidence on the effect of radiation to (sub-volumes of) the heart and the corresponding side-effects will be critically reviewed. Moreover, the time-scale of events occurring will be eluded to. Most data nowadays origin from organ-centered routine clinical follow-up, without involvement of cardiologists or electrophysiologists. Dedicated cardio-oncology clinics including imaging and functional testing may be a way forward for increasing the quality and quantity of follow-up data. Moreover, multidisciplinary survivor-clinics for those patients having been treated many years ago may shed light into the field of cardio-oncology. Jointly, the experts in the field will come up with recommendations on future joint efforts to increase the available data and analytical tools in order to develop even more powerful guidelines for cardio-oncology in the future.

Overview: While individual radiosensitivity is a biological evidence and of societal and ethical interest, its consideration in radiotherapy practise remains unclear, probably because its multiple forms require very specific biomarkers to be assessed. The aim of this session is to present a state-of-art of these questions and to propose some useful recommendations to apply radiosensitivity assays in routine.